| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |